ONCY Oncolytics Biotech, Inc. Common Shares Pharmaceutical Preparations Best Pharmaceutical Stocks 2026 →

ONCY Stock Analysis: Buy, Sell, or Hold?

$0.37
-0.04 (-9.62%) β–Ό
5d: -17.11% 30d: -30.88% 90d: -55.4%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
38/100
Position
OVERSOLD
30-Day Fair Range
$0.42 – $0.54
Position: OVERSOLD
Forward P/E & Valuation
-1.1x
Next 12M consensus est.
Wall Street Target
$4.40
+1082.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.37 / $0.46
Trend: Strong Downtrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: ONCY is down 17.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When ONCY Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: ONCY is currently trading at $0.37, which is considered oversold relative to its 30-day fair value range of $0.42 to $0.54.

Technical Outlook: Technically, ONCY is in a strong downtrend. The price is currently testing key support at $0.37. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.6% recently.

Market Sentiment: ONCY scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.40 (+1082.1%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $0.42 - $0.54
Company Quality Score 38/100 (SELL)
Volume Confirmation HIGH
Confidence Score 52.6%

Trading Range & Key Levels

30-Day Trading Range $0.42 - $0.54
Current vs Trading Range OVERSOLD
Support Level $0.37
Resistance Level $0.46
Current Trend Strong Downtrend
Technical data as of Nov 12, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (33/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-9.6%)
  • BULLISH: Trading 1082.1% below Wall St target ($4.40)
  • WARNING: Composite score 38/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -1.14
Wall Street Target $4.40 (+1082.1%)
Share ONCY Analysis

Share this live ONCY analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (ONCY)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary: Investor presentation for $ONCY has been updated and is now available on the company website.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:03 AM ET
Data refreshes hourly during market hours. Next update: 6:03 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ONCY.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CYTK
Cytokinetics Inc
STRONG BUY
22 analysts
$107 65 BUY
INSM
Insmed Inc
STRONG BUY
24 analysts
$194 37 SELL
MDGL
Madrigal Pharmaceuticals…
STRONG BUY
19 analysts
$689 58 HOLD
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$86 46 HOLD
IMNM
ImmunomeΒ Inc
STRONG BUY
17 analysts
$35 46 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive ONCY Research Pages
ONCY Technical Chart ONCY Price Prediction ONCY Intrinsic Value DCF ONCY Earnings Date ONCY Investment Advisor ONCY Fair Price Analyzer ONCY Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals